Evidence map›Paper›PMID 34846708›Full record

ArticleAdvances in therapy2022

A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'.

Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, Stephan Vavricka, Miguel Bettencourt, Antonio Ramirez de Arellano, Simona Gavata, Neige Morin, William J Valentine, Barnaby Hunt

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Aysegül AksanInterdisciplinary Crohn Colitis Centre, Rhein-Main, Frankfurt am Main, Germany.
Alain SchoepferDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire de Lausanne and University of Lausanne, Lausanne, Switzerland.
Pascal JuilleratGastroenterology, Clinic of Visceral Surgery and Medicine, Bern University Hospital, Bern, Switzerland.
Stephan VavrickaZentrum für Gastroenterologie und Hepatologie, Zürich, Switzerland.
Miguel BettencourtVifor Pharma Group, Villars-sur-Glâne, Switzerland.
Antonio Ramirez de ArellanoVifor Pharma Group, Flughofstrasse 61, 8152, Glattbrugg, Switzerland. antonio.ramirez@viforpharma.com.
Simona GavataVifor Pharma Group, Flughofstrasse 61, 8152, Glattbrugg, Switzerland.
Neige MorinVifor Pharma Group, Villars-sur-Glâne, Switzerland.
William J ValentineOssian Health Economics and Communications, Basel, Switzerland.
Barnaby HuntOssian Health Economics and Communications, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Iron-DeficiencyInflammatory Bowel DiseasesIron DeficienciesCost-Benefit AnalysisHumansIronSwitzerlandIronCostCost-effectivenessInflammatory bowel diseaseIron deficiency anemiaSwitzerland

Identifiers

PMID34846708
PMCPMC8799560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.